Skip to main content

Advertisement

SpringerLink
Log in

Development of myasthenia gravis during treatment of chronic hepatitis C with interferon-alpha and ribavirin

  • Letter to the editor
  • Published:
Journal of Gastroenterology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Author information

Authors and Affiliations

  1. Department of Hepatology, Academic Medical Center, Postbus 22660, 1100 DD Amsterdam, The Netherlands, , , , , , NL

    Christine J. Weegink, Robert A. F. M. Chamuleau & Henk W. Reesink

  2. Department of Neurology, Academic Medical Center, Amsterdam, The Netherlands, , , , , , NL

    Delmar S. M. Molenaar

Authors
  1. Christine J. Weegink
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Robert A. F. M. Chamuleau
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Henk W. Reesink
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Delmar S. M. Molenaar
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Received: January 19, 2001 / Accepted: May 18, 2001

Rights and permissions

Reprints and permissions

About this article

Cite this article

Weegink, C., Chamuleau, R., Reesink, H. et al. Development of myasthenia gravis during treatment of chronic hepatitis C with interferon-alpha and ribavirin. J Gastroenterol 36, 723–724 (2001). https://doi.org/10.1007/s005350170038

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s005350170038

Keywords

Search

Navigation